Matveev et al., 2019 - Google Patents
Novel mouse monoclonal antibodies specifically recognizing β-(1→ 3)-D-glucan antigenMatveev et al., 2019
View HTML- Document ID
- 7797944850867423554
- Author
- Matveev A
- Krylov V
- Khlusevich Y
- Baykov I
- Yashunsky D
- Emelyanova L
- Tsvetkov Y
- Karelin A
- Bardashova A
- Wong S
- Aimanianda V
- Latgé J
- Tikunova N
- Nifantiev N
- Publication year
- Publication venue
- PLoS One
External Links
Snippet
β-(1→ 3)-D-Glucan is an essential component of the fungal cell wall. Mouse monoclonal antibodies (mAbs) against synthetic nona-β-(1→ 3)-D-glucoside conjugated with bovine serum albumin (BSA) were generated using hybridoma technology. The affinity constants of …
- 108010045030 monoclonal antibodies 0 title abstract description 98
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Matveev et al. | Novel mouse monoclonal antibodies specifically recognizing β-(1→ 3)-D-glucan antigen | |
| Torosantucci et al. | Protection by anti-β-glucan antibodies is associated with restricted β-1, 3 glucan binding specificity and inhibition of fungal growth and adherence | |
| Sherrington et al. | Adaptation of Candida albicans to environmental pH induces cell wall remodelling and enhances innate immune recognition | |
| Prados-Rosales et al. | Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine | |
| Matveev et al. | Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan | |
| Polonelli et al. | Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis | |
| Wheeler et al. | A drug-sensitive genetic network masks fungi from the immune system | |
| Feldman et al. | Epidemiology, virulence factors and management of the pneumococcus | |
| Beauvais et al. | Deletion of the α-(1, 3)-glucan synthase genes induces a restructuring of the conidial cell wall responsible for the avirulence of Aspergillus fumigatus | |
| Döring et al. | Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease | |
| Xin et al. | Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis | |
| Chaturvedi et al. | Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis | |
| Gabrielli et al. | Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response | |
| Domanski et al. | Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus | |
| Cenci et al. | Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation | |
| Bashaw et al. | Development of in vitro correlate assays of immunity to infection with Yersinia pestis | |
| Melin et al. | Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae | |
| Hallström et al. | Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen | |
| Tsai et al. | Characterizing the role of cell-wall β-1, 3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37 | |
| Boniche et al. | Immunotherapy against systemic fungal infections based on monoclonal antibodies | |
| Szijártó et al. | Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b: H4 elicit protection in mice | |
| Guachalla et al. | Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3 | |
| Domenech et al. | Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract | |
| Spreghini et al. | Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata | |
| Kottom et al. | Evidence for proinflammatory β-1, 6 glucans in the Pneumocystis carinii cell wall |